---
title: Wellnex Life (ASX:WNX) Q3 FY24 Quarterly Report and Appendix 4C
description: Wellnex Life (ASX:WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement. 
---

[The Latest ](https://www.barclaypearce.com/blog)

# [Wellnex Life (ASX:WNX) Q3 FY24 Quarterly Report and Appendix 4C](https://www.barclaypearce.com/blog/wellnex-life-asxwnx-q3-fy24-quarterly-report-and-appendix-4c)

 Written by [Barclay Pearce Capital](https://www.barclaypearce.com/blog/author/barclay-pearce-capital) | Apr 30, 2024 12:36:36 AM

We are pleased to share [Wellnex Life](https://www.linkedin.com/company/wellnex-life/)'s (ASX:WNX) announcement highlighting the first operating positive cash flow recorded for a quarter of $304,000 compared to -$2.55M in the previous quarter.

A huge congratulations to [George Karafotias](https://www.linkedin.com/in/ACoAAAPdOo8BAt1liFOFUWaEnLGIxmcqxIujwT8), [Zack Bozinovski](https://www.linkedin.com/in/ACoAAAG1z8YB5A5gczK80Grl56ldSGNGk62xZRo), the board and the team at WNX for reaching this exciting milestone!

 

## 30 March 2024: Q3 FY24 Quarterly Report and Appendix 4C

 

### Announcement Highlights

- Cash Receipts for the quarter was $3.12 million with receipts from Pain Away commencing in February.
- First operating positive cashflow recorded for a quarter of $304,000, compared to -$2.55 million in the previous quarter
- Increasing brand sales with the acquisition of Pain Away has increased margins for this quarter to 32% compared to 13% from the prior corresponding period
- Appointment of industry experts to the board of Wellnex increasing its experience and corporate governance
- UK approval received for Wellnex’s TGA registered paracetamol soft gel liquid analgesic to commence sales in the UK with Haleon
- Wellnex signed an international distribution agreement with Homart Pharmaceuticals to take Wellnex’s brands into Asia

Read the full Wellnex Life Half-Year Report & Trading Update [here](https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02800999-3A641496).

 

*To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.*  

[View full post](https://www.barclaypearce.com/blog/wellnex-life-asxwnx-q3-fy24-quarterly-report-and-appendix-4c)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Barclay Pearce Capital"
  },
  "dateModified" : "2024-04-30T00:36:36.723Z",
  "datePublished" : "2024-04-30T00:36:36Z",
  "headline" : "Wellnex Life (ASX:WNX) Q3 FY24 Quarterly Report and Appendix 4C",
  "image" : {
    "@type" : "ImageObject",
    "height" : 350,
    "url" : "https://www.barclaypearce.com.au/hubfs/wellnex-life-barclay-pearce-capital-successful-raise-acquisition-painaway.jpg",
    "width" : 600
  },
  "mainEntityOfPage" : "https://www.barclaypearce.com/blog/wellnex-life-asxwnx-q3-fy24-quarterly-report-and-appendix-4c",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "The Latest"
  }
}
```